<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16795">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02117609</url>
  </required_header>
  <id_info>
    <org_study_id>LRD-2011-PRESAGE</org_study_id>
    <secondary_id>ANR ALIA2010-01306 Presage</secondary_id>
    <nct_id>NCT02117609</nct_id>
  </id_info>
  <brief_title>Effect of a New High-protein Oral Supplement on Functional Parameters in Patients in Nursing Homes</brief_title>
  <acronym>PRESAGE-T2</acronym>
  <official_title>Effet d'Une supplémentation Avec Une Nouvelle préparation hyperprotéinée et Hypercalorique Sur l'évolution Des paramètres Fonctionnels, Nutritionnels et Cognitifs Chez la Personne âgée en Institution</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lactalis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gérontopôle Toulouse</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>U995, Université Lille Nord de France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Research Agency, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lactalis</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine whether a supplementation with a new
      high-protein oral supplement can improve the evolution of functional parameters in elderly
      patients in nursing homes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Change from baseline in 4-meter walking speed</measure>
    <time_frame>After 3 months and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in grip strength</measure>
    <time_frame>After 3 months and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in ADL (Activities Daily Living) score</measure>
    <time_frame>After 3 months and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Geriatric Depression Scale</measure>
    <time_frame>After 3 months and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in quality of life (QOL-AD)</measure>
    <time_frame>After 3 months and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of pathologic adverse events (disease, acute infection, falls, hospitalization)</measure>
    <time_frame>During the 3 months and/or 6 months of consumption</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in body composition measured by bioelectrical impedence analysis (BIA)</measure>
    <time_frame>After 3 months and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in nutritional status (Mini Nutritional Assessment)</measure>
    <time_frame>After 3 months and 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from baseline in blood parameters</measure>
    <time_frame>After 3 months and 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Inflammation markers (TNFalpha, TNF-R1, TNF-R2, IL 15), Fatty acid composition of red blood cell membranes, Fibrinogen, CRP, albumin, prealbumin, orosomucoid, IGF-1, cystein, glutathione peroxidase, oxidized and reduced glutathione</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Malnutrition</condition>
  <arm_group>
    <arm_group_label>New DELICAL formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>New high-protein oral nutrient supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard DELICAL formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard isoenergetic isoprotein formula</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>New DELICAL formula</intervention_name>
    <description>3 months with the option of continuing until 6 months.</description>
    <arm_group_label>New DELICAL formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Standard DELICAL formula</intervention_name>
    <description>3 months with the option of continuing until 6 months.</description>
    <arm_group_label>Standard DELICAL formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man or woman aged more than 60 years old

          -  Living in a nursing home for at least 2 months

          -  Malnourished or at risk of malnutrition (MNA&lt;23.5 or BMI&lt;24 or albumin&lt;35 g/l or
             weight loss of more than 5 kg in the last 6 months)

          -  Without dementia or with moderate dementia (MMSE &gt; or =10/30)

          -  Able to walk without human assistance (technical assistance allowed)

          -  No vitamin D supplementation

          -  Able to follow the study procedures and agreed to consume oral supplement

        Exclusion Criteria:

          -  Severe dementia (MMSE &lt; 10/30)

          -  Enteral nutrition

          -  Severe renal or hepatic impairment

          -  Cancer with chemotherapy

          -  Uncontrolled diabetes

          -  Lactose intolerance

          -  Cow's milk protein allergy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yves Rolland, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gérontopôle Toulouse</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cécile Bonhomme, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Lactalis Nutrition Santé</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Seguy, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>U995, Université Lille Nord France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charlotte Baudry, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Lactalis Recherche et Développement</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yves Rolland</last_name>
    <phone>+335 61 77 64 06</phone>
    <email>rolland.y@chu-toulouse.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nursing homes - Région Midi-Pyrénées</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 17, 2014</lastchanged_date>
  <firstreceived_date>April 16, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Elderly</keyword>
  <keyword>Nursing home</keyword>
  <keyword>Functional impairment</keyword>
  <keyword>High-protein oral supplement</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
